Urinary Tubular Biomarkers for Chronic Kidney Disease

Recruiting now

Conditions studied: Chronic Kidney Disease Stage 3

In brief

Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.

Key facts

Study ID

NCT06732349

Run by

Erasmus Medical Center

People needed

556

Starts

2025-01-01

Expected to finish

2029-12-01

Last updated by the study team

2025-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic kidney disease stage 3 (eGFR 30-59ml/min)

You may not qualify if…

• Active glomerulonephritis treated with immunosuppression
• Kidney transplant recipient
• Current treatment with chemo- or immunotherapy for malignancy

Where it is running

• Erasmus MC — Rotterdam, South Holland, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.